中潤光學(688307.SH):戴斯光電生產的高端濾光片組件間接應用於ASML光刻機產品
格隆匯7月10日丨中潤光學(688307.SH)在投資者互動平臺表示,戴斯光電生產的高端濾光片組件具有透過率點位精準、綜合性能指標領先的特點,間接應用於ASML光刻機產品。表明了戴斯光電在相關產品方面的技術和製造能力得到了業內權威客戶的認可。此外,戴斯光電研製的棱鏡、波片、PBS、柱面鏡、透鏡等光學元件產品,以及聲光調製器、電光調製器、隔離器、2D/3D光學AOI檢測模組等產品也可應用於半導體檢測領域,終端客戶包括華爲等。今後,戴斯光電將進一步拓展半導體領域的產品和客戶,提升戴斯光電在半導體領域的核心競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.